Cardiovascular Research

Cardiology is concerned with general functions of the heart and with the study of cardiovascular diseases.

This area of research is also highly relevant as cardiovascular disease is the leading cause of death in industrialized countries. This gives a special urgency to the study of diseases such as coronary heart disease, myocardial diseases, cardiac arrhythmia and myocardial infarction.

For the research and development of new examination methods in the field of cardiology, we can provide you with the right products. For this, we offer you a comprehensive product range and a reliable service.

Antibodies and ELISA kits for the specific detection of cardiovascular markers
Proinflammatory cytokines such as IL-8, IL-10, IL-12, IL-18, MCP-1 and TGF-ß

Name	Type	Specific against	Item no.	Amount	Price
SB265610	Inhibitors	Other	A14195-50 Adooq	50 mg	Login Compare	SB265610
SB265610	Inhibitors	Other	A14195-100 Adooq	100 mg	Login Compare	SB265610
SB265610	Inhibitors	Other	A14195-500 Adooq	500 mg	Login Compare	SB265610
SB265610	Inhibitors	Other	A14195-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	SB265610
SB225002	Inhibitors	Other	A14209-5 Adooq	5 mg	Login Compare	SB225002
SB225002	Inhibitors	Other	A14209-100 Adooq	100 mg	Login Compare	SB225002
SB225002	Inhibitors	Other	A14209-200 Adooq	200 mg	Login Compare	SB225002
SB225002	Inhibitors	Other	A14209-500 Adooq	500 mg	Login Compare	SB225002
BQ-788	Inhibitors	Other	A14369-10 Adooq	10 mg	Login Compare	BQ-788
BQ-788	Inhibitors	Other	A14369-25 Adooq	25 mg	Login Compare	BQ-788
BQ-788	Inhibitors	Other	A14369-50 Adooq	50 mg	Login Compare	BQ-788
BQ-788	Inhibitors	Other	A14369-100 Adooq	100 mg	Login Compare	BQ-788
Namodenoson (CF-102)	Inhibitors	Other	A14402-1 Adooq	1 mg	Login Compare	Namodenoson (CF-102)
Namodenoson (CF-102)	Inhibitors	Other	A14402-100 Adooq	100 mg	Login Compare	Namodenoson (CF-102)
Namodenoson (CF-102)	Inhibitors	Other	A14402-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	Namodenoson (CF-102)
Digoxin	Inhibitors	Other	A14242-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	Digoxin
(±)-Befunolol	Inhibitors	Other	A19441-1 Adooq	1 mg	Login Compare	(±)-Befunolol
(±)-Befunolol	Inhibitors	Other	A19441-5 Adooq	5 mg	Login Compare	(±)-Befunolol
(±)-Befunolol	Inhibitors	Other	A19441-10 Adooq	10 mg	Login Compare	(±)-Befunolol
(±)-Befunolol	Inhibitors	Other	A19441-50 Adooq	50 mg	Login Compare	(±)-Befunolol
(±)-Befunolol	Inhibitors	Other	A19441-25 Adooq	25 mg	Login Compare	(±)-Befunolol
(±)-Befunolol	Inhibitors	Other	A19441-100 Adooq	100 mg	Login Compare	(±)-Befunolol
trans-Ned 19	Inhibitors	Other	A19327-25 Adooq	25 mg	Login Compare	trans-Ned 19
trans-Ned 19	Inhibitors	Other	A19327-50 Adooq	50 mg	Login Compare	trans-Ned 19
trans-Ned 19	Inhibitors	Other	A19327-100 Adooq	100 mg	Login Compare	trans-Ned 19

Name Price

SB265610

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14195-50
Amount	50 mg
Available

SB265610

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14195-100
Amount	100 mg
Available

SB265610

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14195-500
Amount	500 mg
Available

SB265610

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14195-10mM-D
Amount	10 mM x 1 mL in DMSO
Available

SB225002

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14209-5
Amount	5 mg
Available

SB225002

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14209-100
Amount	100 mg
Available

SB225002

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14209-200
Amount	200 mg
Available

SB225002

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14209-500
Amount	500 mg
Available

BQ-788

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14369-10
Amount	10 mg
Available

BQ-788

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14369-25
Amount	25 mg
Available

BQ-788

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14369-50
Amount	50 mg
Available

BQ-788

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14369-100
Amount	100 mg
Available

Namodenoson (CF-102)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14402-1
Amount	1 mg
Available

Namodenoson (CF-102)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14402-100
Amount	100 mg
Available

Namodenoson (CF-102)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14402-10mM-D
Amount	10 mM x 1 mL in DMSO
Available

Digoxin

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A14242-10mM-D
Amount	10 mM x 1 mL in DMSO
Available

(±)-Befunolol

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19441-1
Amount	1 mg
Available

(±)-Befunolol

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19441-5
Amount	5 mg
Available

(±)-Befunolol

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19441-10
Amount	10 mg
Available

(±)-Befunolol

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19441-50
Amount	50 mg
Available

(±)-Befunolol

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19441-25
Amount	25 mg
Available

(±)-Befunolol

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19441-100
Amount	100 mg
Available

trans-Ned 19

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19327-25
Amount	25 mg
Available

trans-Ned 19

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19327-50
Amount	50 mg
Available

trans-Ned 19

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19327-100
Amount	100 mg
Available

Cardiovascular Research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Cardiovascular Research

Contact

About Hölzel

Service

Infodesk